In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments
In this unprecedented age of technology and communication, many wonder why the healthcare industry has traditionally not been on the cutting edge.
Their concept is simple: positive thoughts reduce depression. Train your brain to increase positive thoughts.
Reed Smith LLP, a global business law firm, recently issued a JOBS Act bulletin to its network. The bulletin, co-authored by seven partners on both coasts, summarizes and analyzes the JOBS Act.
Part Three of our Special Report analyzes what may be one of the first ‘test cases’ of the new patent infringement precedent.
Part two of our Special Report highlight an important case that may significantly affect the patent infringement landscape. Shares of Myriad Genetics fell 10 percent in the wake of the Mayo ruling.
“Approval to sell RenalGuard in Brazil is yet another significant development for PLC,” said Mark R. Tauscher, President and Chief Executive Officer of PLC Systems.
Strategically, the organization has done a good job in moving drugs through clinical trials but lacks venture capital funding. But the benefit investors stand to gain is a major stakehold in the drug with a low investment.
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
OneMedPlace is publishing a special in-depth look into the state of patent infringement in drug manufacturing.
Copyright © 2025 | WordPress Theme by MH Themes